SYROS PHARMACEUTICALS (SYRS) Debt by Year
SYROS PHARMACEUTICALS INC carried $34.6M in long-term debt against $139.5M in cash and equivalents at the end of fiscal year 2023. Long-term debt fell 15.0% from the prior fiscal year. The table below carries 10 fiscal years, from 2014 to 2023, and the quarters SYROS PHARMACEUTICALS INC has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
SYRS Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
SYRS Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q | Q2'2310-Q | Q1'2310-Q | Q4'2210-K | Q3'2210-Q | Q2'2210-Q | Q1'2210-Q | Q4'2110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $41.1M+4.3% | $40.9M0.0% | $29.7M-24.1% | $34.6M-15.0% | $39.4M-2.7% | $40.9M+20.5% | $39.1M+0.9% | $40.6M+1.0% | $40.5M+1.1% | $34.0M-14.9% | $38.8M-2.4% | $40.3M+1.8% |
| Cash & Equivalents | $58.3M-48.1% | $79.0M-31.6% | $83.5M-20.3% | $139.5M-16.7% | $112.2M-34.6% | $115.4M+95.5% | $104.8M+50.6% | $167.5M+81.4% | $171.5M+48.6% | $59.1M-63.3% | $69.6M-68.7% | $92.3M-46.9% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More SYROS PHARMACEUTICALS INC financials
Frequently Asked Questions
What was SYROS PHARMACEUTICALS INC's long-term debt in fiscal year 2023?
SYROS PHARMACEUTICALS INC carried $34.6M in long-term debt against $139.5M in cash and equivalents at the end of fiscal year 2023.
How fast is SYROS PHARMACEUTICALS INC's long-term debt growing?
SYROS PHARMACEUTICALS INC (SYRS) long-term debt fell by 15.0% year over year, from $40.6M to $34.6M in fiscal year 2023.
What was SYROS PHARMACEUTICALS INC's long-term debt in the most recent quarter?
SYROS PHARMACEUTICALS INC (SYRS) reported $41.1M in long-term debt in Q3 2024. This represents an increase of 4.3% from the same quarter a year earlier.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what SYROS PHARMACEUTICALS INC (SYRS) reported on that line in every period on record.